NO20020337L - Preparat for forebyggelse av muskelutmattelse og skjelettmuskeltilpasning til anstrengende utövelse - Google Patents

Preparat for forebyggelse av muskelutmattelse og skjelettmuskeltilpasning til anstrengende utövelse

Info

Publication number
NO20020337L
NO20020337L NO20020337A NO20020337A NO20020337L NO 20020337 L NO20020337 L NO 20020337L NO 20020337 A NO20020337 A NO 20020337A NO 20020337 A NO20020337 A NO 20020337A NO 20020337 L NO20020337 L NO 20020337L
Authority
NO
Norway
Prior art keywords
muscle
preparation
adaptation
strenuous exercise
fatigue prevention
Prior art date
Application number
NO20020337A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020337D0 (no
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20020337D0 publication Critical patent/NO20020337D0/no
Publication of NO20020337L publication Critical patent/NO20020337L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20020337A 1999-07-23 2002-01-22 Preparat for forebyggelse av muskelutmattelse og skjelettmuskeltilpasning til anstrengende utövelse NO20020337L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000467A IT1306173B1 (it) 1999-07-23 1999-07-23 Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
PCT/IT2000/000308 WO2001006873A1 (fr) 1999-07-23 2000-07-21 Composition destinee a la prevention de la fatigue musculaire et a une meilleure adaptation du muscle squelettique aux exercices difficiles

Publications (2)

Publication Number Publication Date
NO20020337D0 NO20020337D0 (no) 2002-01-22
NO20020337L true NO20020337L (no) 2002-03-22

Family

ID=11406897

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020337A NO20020337L (no) 1999-07-23 2002-01-22 Preparat for forebyggelse av muskelutmattelse og skjelettmuskeltilpasning til anstrengende utövelse

Country Status (21)

Country Link
US (1) US6602512B1 (fr)
EP (1) EP1196046B1 (fr)
AR (1) AR024820A1 (fr)
AT (1) ATE263496T1 (fr)
AU (1) AU778647B2 (fr)
CA (1) CA2377128C (fr)
CZ (1) CZ20023A3 (fr)
DE (1) DE60009704T2 (fr)
DK (1) DK1196046T3 (fr)
ES (1) ES2216931T3 (fr)
HU (1) HU228838B1 (fr)
IL (1) IL147408A0 (fr)
IT (1) IT1306173B1 (fr)
MX (1) MXPA02000780A (fr)
NO (1) NO20020337L (fr)
PL (1) PL204743B1 (fr)
PT (1) PT1196046E (fr)
SK (1) SK942002A3 (fr)
TN (1) TNSN00161A1 (fr)
TR (1) TR200200179T2 (fr)
WO (1) WO2001006873A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
US6849613B2 (en) 2001-08-29 2005-02-01 Kedar N. Prasad Multiple antioxidant micronutrients
US7449451B2 (en) * 2001-08-29 2008-11-11 Premier Micronutrient Corporation Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks
DE10160485A1 (de) * 2001-12-08 2003-10-02 Degussa Verwendung von Kreatin und/oder einem seiner physiologisch geeigneten Derivate zur Prävention oder Linderung von nicht krankheitsbedingten Beeinträchtigungen und/oder Störungen der Muskelfunktion
DE102004009962A1 (de) * 2004-03-01 2005-09-22 Degussa Ag Verwendung von Guanidin-Verbindungen als physiologisches Stärkungsmittel in Form von Nahrungsergänzungsmitteln, Futtermittelzusätzen, in kosmetischen Zubereitungen und als Pflanzenstärkungsmittel
US20060083793A1 (en) * 2004-09-29 2006-04-20 Gardiner Paul T Nutritional composition for promoting muscle performance and acting as hydrogen (H+) blocker
EP1904070A4 (fr) * 2005-07-07 2009-09-02 H3 Formulations Ltd Supplément alimentaire pour l amélioration de la masse musculaire squelettique, la diminution de la dégradation des protéines musculaires, la diminution du nombre de voies du catabolisme musculaire et la diminution du catabolisme des cellules musculaires.
GB0606864D0 (en) * 2006-04-05 2006-05-17 Univ Nottingham Increades fatty acid oxidation
WO2008025114A1 (fr) * 2006-08-30 2008-03-06 Aplodan Formulations Ltd. Augmentation de la disponibilité de l'atp par inhibition de la fuite de créatine kinase (ck) résultant d'un exercice intense
US7375097B2 (en) * 2006-08-30 2008-05-20 Aplodan Formulations Ltd. Increasing ATP availability by inhibition of creatine kinase (CK) leakage resulting from high-intensity exercise
US7368441B2 (en) * 2006-08-30 2008-05-06 Aplodan Formulations Ltd. Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions
WO2008025115A1 (fr) * 2006-08-30 2008-03-06 Aplodan Formulations Ltd. Méthode destinée à augmenter les concentrations intracellulaires du phosphate et la force des contractions musculaires
US20100124587A1 (en) * 2008-11-17 2010-05-20 Heuer Marvin A Creatine-containing vitamin and mineral composition
US20110105786A1 (en) * 2009-11-02 2011-05-05 Tianjin Tiancheng Pharmaceutical Co., Ltd. Creatinol o-phosphate and synthesis method thereof
CN103429234B (zh) 2010-12-10 2016-10-05 布罗迪健康科学有限公司 茉莉酮酸酯治疗膀胱功能障碍的用途
CA2951567C (fr) 2014-06-12 2023-10-31 Lonza, Inc. Methode pour diminuer les lesions des muscles squelettiques et/ou le stress oxydatif chez les mammiferes
US10499682B2 (en) 2014-08-25 2019-12-10 New Age Beverage Corporation Micronutrient formulation in electronic cigarettes
BR112018007434A2 (pt) 2015-10-27 2018-10-23 Cytozyme Animal Nutrition Inc composições para nutrição animal, usos e métodos relacionados
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
EP3389385A1 (fr) 2015-12-18 2018-10-24 Lonza Inc. Procédé et composition pour augmenter la synthèse de protéine musculaire et/ou la résistance fonctionnelle chez des mammifères, et procédé de production de composition
WO2022215085A1 (fr) 2021-04-06 2022-10-13 Celagenex Research (India) Pvt. Ltd. Composition synergique pour potentialiser l'atp stabilisée

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IT1124697B (it) * 1979-10-26 1986-05-14 Simes Derivati di creatinolo o-fosfato ad azione terapeutica,procedimento per la sua preparazione e relativ-e composizioni farmaceutiche
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
EP0891719A1 (fr) * 1997-07-14 1999-01-20 N.V. Nutricia Composition dietique contenant de la methionine
WO1999051097A1 (fr) * 1998-04-02 1999-10-14 Avicena Group, Inc. Compositions contenant de la creatine combinee a un second agent
ES2146555B1 (es) * 1999-01-22 2001-03-01 Helsint S A L Empleo de formulaciones a base de fracciones hidrosolubles de phlebodium decumanum (exply-37) y/o polypodium leucotomos como complemento nutricional en la prevencion y reversion del sindrome de sobresfuerzo fisico.

Also Published As

Publication number Publication date
ES2216931T3 (es) 2004-11-01
DK1196046T3 (da) 2004-08-02
TNSN00161A1 (fr) 2005-11-10
DE60009704T2 (de) 2005-04-14
AU6468700A (en) 2001-02-13
TR200200179T2 (tr) 2002-06-21
PL352683A1 (en) 2003-09-08
SK942002A3 (en) 2002-05-09
PT1196046E (pt) 2004-08-31
AR024820A1 (es) 2002-10-23
CA2377128C (fr) 2009-09-22
NO20020337D0 (no) 2002-01-22
ITRM990467A1 (it) 2001-01-23
PL204743B1 (pl) 2010-02-26
HU228838B1 (en) 2013-06-28
CZ20023A3 (cs) 2002-06-12
AU778647B2 (en) 2004-12-16
HUP0202298A2 (en) 2002-10-28
IT1306173B1 (it) 2001-05-30
US6602512B1 (en) 2003-08-05
ATE263496T1 (de) 2004-04-15
HUP0202298A3 (en) 2005-07-28
IL147408A0 (en) 2002-08-14
CA2377128A1 (fr) 2001-02-01
DE60009704D1 (de) 2004-05-13
EP1196046A1 (fr) 2002-04-17
ITRM990467A0 (it) 1999-07-23
EP1196046B1 (fr) 2004-04-07
WO2001006873A1 (fr) 2001-02-01
MXPA02000780A (es) 2002-08-20

Similar Documents

Publication Publication Date Title
NO20020337L (no) Preparat for forebyggelse av muskelutmattelse og skjelettmuskeltilpasning til anstrengende utövelse
BR9807905A (pt) Suplemento nutritivo para facilitar a adaptação dos músculos esqueletais a exercìcios extenuantes e contra atacar a fadiga em indivìduos astênicos
RU2005101764A (ru) Питательная композиция для детоксикации и предупреждения рака
ES2144288T3 (es) Carne vegetal.
HUP0102926A2 (hu) Karnitint és inozit-foszfátot tartalmazó, táplálékkiegészítőként vagy gyógyszerként alkalmazható készítmény
CN100425162C (zh) 五指毛桃汤料
CN101380104A (zh) 治疗钙流失的药膳疗法
CN110339319A (zh) 一种调节肠胃功能的丁砂膏及其制备方法
CN101564367A (zh) 中草药平衡修复润肤美白面膜
CN103494275B (zh) 一种娃娃鱼的汤煲组料
RU2297843C2 (ru) Средство эндоэкологической коррекции и способ эндоэкологической коррекции, основанный на его применении
CN105495561A (zh) 素鸡腿及其制备方法
KR100655148B1 (ko) 한방처방에 따른 기능성 멸치 및 그의 가공방법
CN109566826A (zh) 一种抗衰老提高免疫力美容的组合物
Laursen Free radicals and antioxidant vitamins: optimizing the health of the athlete
CN107569640A (zh) 强骨健骼散制备方法
CN107198063A (zh) 一种胶原木瓜果粒果汁饮品及其制备方法
CN104983135A (zh) 一种含中药的蒲草鞋垫及其制备方法
CN107535856A (zh) 石斛炖蛇肉的做法
CN104687108B (zh) 一种蚝干的制备方法
JP2004203896A (ja) 化粧用パックとその製造方法
Marin et al. Peloidotherapy in osteoarthritis-modulation of oxidative stress
CN106858378A (zh) 一种猪脚的卤制方法
RU2540915C1 (ru) Способ коррекции морфофункционального состояния спортсменов на различных этапах тренировочно-соревновательного цикла
CN109789178A (zh) 影响心血管效率的营养补充剂